Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
IBRX · NASDAQ · Biological Products, (No Diagnostic Substances)
$6.02−0.55 (−8.37%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
Immunitybio (IBRX) · oqro.io/stocks/IBRX · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
Politician trade (House) · Transaction Sep 30, 2026 · Disclosed Oct 12, 2026
Disclosed purchase of IBRX — reported range $1,001 - $15,000SourcePolitician trade (House) · Transaction Sep 28, 2026 · Disclosed Oct 12, 2026
Disclosed purchase of IBRX — reported range $1,001 - $15,000SourceInsider trade · Traded Oct 2, 2026 · Filed Oct 6, 2026
Director sold ~$851K of IBRX shares in the open marketSourceInsider trade · Traded Oct 5, 2026 · Filed Oct 6, 2026
Director sold ~$269K of IBRX shares in the open marketSourcePlanned sale · Planned for Oct 5, 2026 · Notice filed Oct 5, 2026
Officer filed to sell about $7.66M of IBRX stockSourcePlanned sale · Planned for Oct 2, 2026 · Notice filed Oct 2, 2026
Director filed to sell about $752K of IBRX stockSourcePolitician trade (House) · Transaction Mar 6, 2023 · Disclosed Apr 17, 2023
Disclosed sale of IBRX — reported range $1,001 - $15,000Source